| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $175,177 | 1 | 100 |
| Stewart Richard Alistair | director | 0 | $0 | 1 | $175,177 | $-175,177 |
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD …
Over the last 12 months, insiders at Achieve Life Sciences, Inc. have bought $0 and sold $175,177 worth of Achieve Life Sciences, Inc. stock.
On average, over the past 5 years, insiders at Achieve Life Sciences, Inc. have bought $58,895 and sold $630,087 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $28,598 was made by Stewart Richard Alistair (Chieve Executive Officer) on 2025‑03‑17.
| 2026-08-19 | Sale | Stewart Richard Alistair | director | 20,626 0.02% | $8.49 | $175,177 | -13.13% | |
| 2025-09-18 | Sale | Stewart Richard Alistair | Chief Executive Officer | 129,501 0.2578% | $2.92 | $378,143 | +65.16% | |
| 2025-09-18 | Sale | Oki Mark K | Chief Financial Officer | 50,060 0.0997% | $2.92 | $146,175 | +65.16% | |
| 2025-09-04 | Sale | KING THOMAS BRAXTON | director | 139,858 0.2717% | $2.77 | $387,407 | +66.49% | |
| 2025-09-04 | Sale | JACOBS CINDY | President & CMO | 27,629 0.0537% | $2.77 | $76,532 | +66.49% | |
| 2025-09-04 | Sale | Xinos Jaime | Chief Commercial Officer | 20,854 0.0405% | $2.77 | $57,766 | +66.49% | |
| 2025-09-04 | Sale | Wan Jerry | Principal Accounting Officer | 14,070 0.0273% | $2.77 | $38,974 | +66.49% | |
| 2025-03-17 | Stewart Richard Alistair | Chieve Executive Officer | 10,000 0.0283% | $2.86 | $28,598 | +12.03% | ||
| 2025-03-17 | Oki Mark K | Chief Financial Officer | 10,000 0.0286% | $2.89 | $28,887 | +12.03% | ||
| 2024-03-04 | Bencich John | CEO | 10,000 0.0492% | $4.58 | $45,850 | +2.26% | ||
| 2024-03-04 | Stewart Richard Alistair | Executive Chairman | 10,000 0.0492% | $4.58 | $45,850 | +2.26% | ||
| 2023-05-30 | Bencich John | CEO | 5,000 0.0246% | $5.50 | $27,500 | -26.36% | ||
| 2022-11-18 | Bencich John | CEO | 22,000 – | $0 | $0 | +108.16% | ||
| 2021-05-27 | Bencich John | CEO | 6,000 0.0716% | $7.00 | $42,000 | -3.40% | ||
| 2019-06-11 | Sale | ARMISTICE CAPITAL, LLC | 10 percent owner | 312,145 4.6633% | $3.11 | $972,288 | -71.03% | |
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10 percent owner | 12,813 0.2335% | $3.80 | $48,689 | -71.03% | ||
| 2019-05-23 | Stewart Richard Alistair | Chairman & CEO | 17,500 0.2417% | $3.61 | $63,093 | -74.93% | ||
| 2016-08-19 | Sale | Bencich John | CFO | 2,760 0.0092% | $0.57 | $1,573 | -21.05% | |
| 2016-06-13 | Sale | Cormack Scott Daniel | President and CEO | 9,712 0.032% | $1.03 | $9,959 | -50.96% | |
| 2016-06-13 | Sale | JACOBS CINDY | EVP, CMO | 2,874 0.0095% | $1.03 | $2,947 | -50.96% |
| Stewart Richard Alistair | director | 208249 0.2024% | $1.4M | 3 | 2 | <0.0001% |
| COHEN STEVEN A/SAC CAPITAL MGMT LP | 10 percent owner | 1454752 1.4137% | $9.79M | 1 | 0 | |
| S A C CAPITAL MANAGEMENT L L C | 10 percent owner | 1454752 1.4137% | $9.79M | 1 | 0 | |
| SAC CAPITAL ADVISORS LLC | 10 percent owner | 1454752 1.4137% | $9.79M | 1 | 0 | |
| ARMISTICE CAPITAL, LLC | 10 percent owner | 1026000 0.9971% | $6.9M | 1 | 1 | <0.0001% |
| SAC CAPITAL ASSOCIATES LLC | 10 percent owner | 902376 0.8769% | $6.07M | 1 | 0 | |
| Cormack Scott Daniel | President and CEO | 129428 0.1258% | $871,050.44 | 1 | 12 | |
| Oki Mark K | Chief Financial Officer | 127940 0.1243% | $861,036.20 | 1 | 1 | +12.03% |
| Bencich John | CEO | 76724 0.0746% | $516,352.52 | 4 | 3 | <0.0001% |
| Anderson Stephen Charles | CFO and Secretary | 13000 0.0126% | $87,490.00 | 3 | 0 | |
| DUNBAR GEORGE W JR | director | 3250 0.0032% | $21,872.50 | 1 | 0 | |
| Lawrence Cameron William | Principal Financial Officer | 3050 0.003% | $20,526.50 | 1 | 0 | |
| PARKER H STEWART | director | 3000 0.0029% | $20,190.00 | 1 | 0 | |
| GOLDSTEIN JACK | director | 1000 0.001% | $6,730.00 | 1 | 0 | |
| MATTINGLY MARTIN A | director | 1000 0.001% | $6,730.00 | 1 | 0 |
$100,473,344 | 83 | 9.53% | $826.91M | |
$860,541,348 | 82 | -5.10% | $649.64M | |
$1,108,102,085 | 66 | 36.91% | $755.04M | |
$59,156,363 | 22 | 29.25% | $686.5M | |
$22,365,077 | 19 | -27.47% | $674.89M |
| Increased Positions | 51 | +83.61% | 9M | +60.14% |
| Decreased Positions | 22 | -36.07% | 2M | -9.91% |
| New Positions | 27 | New | 2M | New |
| Sold Out Positions | 10 | Sold Out | 734,630 | Sold Out |
| Total Postitions | 90 | +47.54% | 23M | +50.23% |
| Propel Bio Management, Llc | $18,819.00 | 7.14% | 3.79M | -2M | -38.46% | 2025-09-30 |
| Vanguard Group Inc | $12,235.00 | 4.64% | 2.46M | +311,925 | +14.51% | 2025-09-30 |
| Simplify Asset Management Inc. | $5,887.00 | 2.24% | 1.18M | 0 | 0% | 2025-09-30 |
| Marshall Wace, Llp | $3,851.00 | 1.46% | 774,853 | +774,853 | New | 2025-09-30 |
| Nantahala Capital Management, Llc | $3,225.00 | 1.22% | 648,885 | -250,000 | -27.81% | 2025-09-30 |
| Geode Capital Management, Llc | $2,520.00 | 0.96% | 506,977 | +144,777 | +39.97% | 2025-09-30 |
| Pathstone Holdings, Llc | $2,495.00 | 0.95% | 502,000 | +502,000 | New | 2025-09-30 |
| Raymond James Financial Inc | $2,268.00 | 0.86% | 456,372 | +161,314 | +54.67% | 2025-09-30 |
| Clearline Capital Lp | $2,243.00 | 0.85% | 451,219 | -875,040 | -65.98% | 2025-09-30 |
| Two Sigma Investments, Lp | $2,182.00 | 0.83% | 439,064 | +439,064 | New | 2025-09-30 |